Your browser doesn't support javascript.
loading
Transglutaminase 2 induces intrinsic EGFR-TKI resistance in NSCLC harboring EGFR sensitive mutations.
Choi, Junyoung; Yoon, Shinkyo; Kim, Deokhoon; Moon, Yong Wha; Lee, Chang Hoon; Seo, Seyoung; Cheon, Jaekyung; Gho, Yong Song; Kim, Changhoon; Lee, Eung Ryoung; Kim, Soo-Youl; Lee, Kyoungmin; Ha, Joo Young; Park, Sook Ryun; Kim, Sang-We; Park, Kang-Seo; Lee, Dae Ho.
Afiliação
  • Choi J; Department of Oncology, Asan Medical Center, College of Medicine, University of Ulsan Seoul 05505, Republic of Korea.
  • Yoon S; Department of Biomedical Sciences, College of Medicine, University of Ulsan Seoul 05505, Republic of Korea.
  • Kim D; Department of Oncology, Asan Medical Center, College of Medicine, University of Ulsan Seoul 05505, Republic of Korea.
  • Moon YW; Center for Cancer Genome Discovery, Asan Institute for Life Science, Asan Medical Center Seoul 05505, Republic of Korea.
  • Lee CH; Medical Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University Seongnam-si, Gyeonggi-do, 463-712, Republic of Korea.
  • Seo S; Bio & Drug Discovery Division, Center for Drug Discovery Technology, Korea Research Institute of Chemical Technology (KRICT) Daejeon, Republic of Korea.
  • Cheon J; Department of Oncology, Asan Medical Center, College of Medicine, University of Ulsan Seoul 05505, Republic of Korea.
  • Gho YS; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine 877 Bangeojinsunhwan-doro, Dong-gu, Ulsan 44033, Republic of Korea.
  • Kim C; Department of Life Sciences, Pohang University of Science and Technology (POSTECH) 77 Cheongam-ro, Nam-gu, Pohang 37673, Republic of Korea.
  • Lee ER; Bioinformatics Institute, Macrogen Inc. Seoul 08511, Republic of Korea.
  • Kim SY; Bioinformatics Institute, Macrogen Inc. Seoul 08511, Republic of Korea.
  • Lee K; Tumor Microenvironment Branch, Division of Cancer Biology, Research Institute, National Cancer Center Goyang 10408, Republic of Korea.
  • Ha JY; Department of Oncology, Asan Medical Center, College of Medicine, University of Ulsan Seoul 05505, Republic of Korea.
  • Park SR; Department of Oncology, Asan Medical Center, College of Medicine, University of Ulsan Seoul 05505, Republic of Korea.
  • Kim SW; Department of Oncology, Asan Medical Center, College of Medicine, University of Ulsan Seoul 05505, Republic of Korea.
  • Park KS; Department of Oncology, Asan Medical Center, College of Medicine, University of Ulsan Seoul 05505, Republic of Korea.
  • Lee DH; Department of Oncology, Asan Medical Center, College of Medicine, University of Ulsan Seoul 05505, Republic of Korea.
Am J Cancer Res ; 9(8): 1708-1721, 2019.
Article em En | MEDLINE | ID: mdl-31497352
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article